Rational design of novel red-shifted BRET pairs: Platforms for real-time single-chain protease biosensors

Biotechnology Progress

Volumn 25, Issue 2, 2009, Pages 559-569

  Gammon, Seth T ^a   Villalobos, Victor M ^a   Roshal, Mikhail ^a,b   Samrakandi, Mustapha ^a   Piwnica Worms, David ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Apoptosis; BRET; D luciferin; Red shifted

Indexed keywords

APOPTOSIS; BIOLUMINESCENCE RESONANCE ENERGY TRANSFER; BRET; CASPASE; CASPASES; D-LUCIFERIN; ENERGY DONORS; HIGH SIGNAL-TO-NOISE RATIO; HIGH-THROUGHPUT SCREENING; IN-VITRO; LIVE CELL; LONGITUDINAL STUDY; RATIONAL DESIGN; RED-SHIFTED; RENILLA LUCIFERASE; RESISTANT CELLS;

CELL CULTURE; CELL DEATH; ENERGY TRANSFER; FADING (RADIO); FLUOROPHORES; PLANTS (BOTANY); SIGNAL TO NOISE RATIO; SIGNAL TRANSDUCTION;

BIOSENSORS;

COLEOPTERA; ELATERIDAE; RENILLA; RENILLA LUCIFERASE;

BENZOTHIAZOLE DERIVATIVE; D-LUCIFERIN; LUCIFERIN; PEPTIDE HYDROLASE; RENILLA LUCIFERIN 2 MONOOXYGENASE;

ARTICLE; CELL LINE; CHEMISTRY; ENERGY TRANSFER; EVALUATION; GENETIC PROCEDURES; GENETICS; HUMAN; LUMINESCENCE; METHODOLOGY;

BENZOTHIAZOLES; BIOSENSING TECHNIQUES; CELL LINE; ENERGY TRANSFER; HUMANS; LUCIFERASES, RENILLA; LUMINESCENT MEASUREMENTS; PEPTIDE HYDROLASES;

EID: 66149166193     PISSN: 87567938     EISSN: None     Source Type: Journal    
DOI: 10.1002/btpr.144     Document Type: Article

References (50)

1. Carragher NO. Calpain inhibition: a therapeutic strategy targeting multiple disease states. Curr Pharm Des. 2006;12:615-638.
2. Meng XW, Lee SH, Kaufmann SH. Apoptosis in the treatment of cancer: a promise kept? Curr Opin Cell Biol. 2006;18:668-676.
3. Budd RC. Activation-induced cell death. Curr Opin Immunol. 2001;13:356-362.
4. Bates SM, Weitz JI. The status of new anticoagulants. Br J Haematol. 2006;134:3-19.
5. Fingleton B. Matrix metalloproteinases as valid clinical targets. Curr Pharm Des. 2007;13:333-346.
6. Hsu JT, Wang HC, Chen GW, Shih SR. Antiviral drug discovery targeting to viral proteases. Curr Pharm Des. 2006;12:1301-1314.
7. Rossetto O, de Bernard M, Pellizzari R, Vitale G, Caccin P, Schiavo G, Montecucco C. Bacterial toxins with intracellular protease activity. Clin Chim Acta. 2000;291:189-199.
8. Timmer JC, Salvesen GS. Caspase substrates. Cell Death Differ. 2007;14:66-72.
9. Cuerrier D, Moldoveanu T, Davies PL. Determination of peptide substrate specificity for mu-calpain by a peptide library-based approach: the importance of primed side interactions. J Biol Chem. 2005;280:40632-40641.
10. Dutta S, Chiu YC, Probert AW, Wang KK. Selective release of calpain produced alphalI-spectrin (alpha-fodrin) breakdown products by acute neuronal cell death. Biol Chem. 2002;383:785-791.
11. Belloc F, Belaud-Rotureau MA, Lavignolle V, Bascans E, Braz-Pereira E, Durrieu F, Lacombe F. Flow cytometry detection of caspase 3 activation in preapoptotic leukemic cells. Cytometry. 2000;40:151-160.
12. Bullok KE, Maxwell D, Kesarwala AH, Gammon, S, Prior JL, Snow M, Stanley S, Piwnica-Worms D. Biochemical and in vivo characterization of a small, membrane-permeant, caspase-activatable far-red fluorescent peptide for imaging apoptosis. Biochemistry. 2007;46:4055-4065.
13. Thornberry NA, Rano TA, Peterson EP, Rasperi DM, Timkey T, Garcia-Calvo M, Houtzageri VM, Nordstromi PA, Royi S, Vaillancourti JP, Chapman KT, Nicholsoni DW. A combinatorial approach defines specificities of members of the caspase family and granzyme B: functional relationships established for key mediators of apoptosis. J Biol Chem. 1997;272:17907-17911.
14. Jiang T, Olson E, Nguyen Q, Roy M, Jennings P, Tsien R. Tumor imaging by means of proteolytic activation of cell-penetrating peptides. Proc Natl Acad Sci USA. 2004;101:17867-17872.
15. Ward MW, Rehm M, Duessmann H, Kacmar S, Concannon CG, Prehn JH. Real time single cell analysis of Bid cleavage and Bid translocation during caspase-dependent and neuronal caspase-independent apoptosis. J Biol Chem. 2006;281:5837-5844.
16. Hu K, Clement JF, Abrahamyan L, Strebel K, Bouvier M, Kleiman L, Mouland AJ. A human immunodeficiency virus type 1 protease biosensor assay using bioluminescence resonance energy transfer. J Virol Methods. 2005;128:93-103.
17. Xu Y, Piston DW, Johnson CH. A bioluminescence resonance energy transfer (BRET) system: application to interacting circadian clock proteins. Proc Natl Acad Sci USA. 1999;96:151-156.
18. Bertrand L, Parent S, Caron M, Legault M, Joly E, Angers S, Bouvier M, Brown M, Houle B, Menard L. The BRET2/arrestin assay in stable recombinant cells: a platform to screen for compounds that interact with G protein-coupled receptors (GPCRS). J Recept Signal Transduct Res. 2002;22:533-541.
19. Pfleger KD, Dromey JR, Dalrymple MB, Lim EM, Thomas WG, Eidne KA. Extended bioluminescence resonance energy transfer (eBRET) for monitoring prolonged protein-protein interactions in live cells. Cell Signal. 2006;18:1664-1670.
20. De A, Gambhir SS. Noninvasive imaging of protein-protein interactions from live cells and living subjects using bioluminescence resonance energy transfer. FASEB J. 2005;19:2017-2019.
21. Arai R, Nakagawa H, Kitayama A, Ueda H, Nagamune T. Detection of protein-protein interaction by bioluminescence resonance energy transfer from firefly luciferase to red fluorescent protein. J Biosci Bioeng. 2002;94:362-364.
22. Arai R, Nakagawa H, Tsumoto K, Mahoney W, Kumagai I, Ueda H, Nagamune T. Demonstration of a homogeneous non-competitive immunoassay based on bioluminescence resonance energy transfer. Anal Biochem. 2001;289:77-81.
23. Baird GS, Zacharias DA, Tsien RY. Biochemistry, mutagenesis, and oligomerization of DsRed, a red fluorescent protein from coral. Proc Natl Acad Sci USA. 2000;97:11984-11989.
24. Zhao H, Doyle TC, Coquoz O, Kalish F, Rice BW, Contag CH. Emission spectra of bioluminescent reporters and interaction with mammalian tissue determine the sensitivity of detection in vivo. J Biomed Opt. 2005;10:41210.
25. Seliger H, McElroy W. The colors of firefly bioluminescence: enzyme configuration and species specificity. Proc Natl Acad Sci USA. 1964;52:75-81.
26. Shaner NC, Campbell RE, Steinbach PA, Giepmans BN, Palmer AE, Tsien RY. Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein. Nat Biotechnol. 2004;22:1567-1572.
27. Angers S, Salahpour A, Joly E, Hilairet S, Chelsky D, Dennis M, Bouvier M. Detection of beta 2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET). Proc Natl Acad Sci USA. 2000;97:3684-3689.
28. Bevington PR, Robinson DK. Data Reduction and Error Analysis for the Physical Sciences. McGraw-Hill Science/Engineering/Math; New York, 2002.
29. Jares-Erijman EA, Jovin TM. FRET imaging. Nat Biotechnol. 2003;21:1387-1395.
30. Ramsay D, Kellett E, McVey M, Rees S, Milligan G. Homo- and hetero-oligomeric interactions between G-protein-coupled receptors in living cells monitored by two variants of bioluminescence resonance energy transfer (BRET): hetero-oligomers between receptor subtypes form more efficiently than between less closely related sequences. Biochem J. 2002;365(Part 2):429-440.
31. Boute N, Jockers R, Issad T. The use of resonance energy transfer in high-throughput screening: BRET versus FRET. Trends Pharmacol Sci. 2002;23:351-354.
32. Pfleger KD, Eidne KA. Illuminating insights into protein-protein interactions using bioluminescence resonance energy transfer (BRET). Nat Methods. 2006;3:165-174.
33. Curie T, Rogers KL, Colasante C, Brulet P. Red-shifted aequorin-based bioluminescent reporters for in vivo imaging of ca(2+) signaling. Mol Imaging. 2007;6:30-42.
34. McNamara G, Gupta A, Reynaert J, Coates TD, Boswell C. Spectral imaging microscopy web sites and data. Cytometry A. 2006;69:863-871.
35. Evers TH, van Dongen EM, Faesen AC, Meijer EW, Merkx M. Quantitative understanding of the energy transfer between fluorescent proteins connected via flexible peptide linkers. Biochemistry. 2006;45:13183-13192.
36. Bevis BJ, Glick BS. Rapidly maturing variants of the Discosoma red fluorescent protein (DsRed). Nat Biotechnol. 2002;20:83-87.
37. Lambert JC, Wang GW, Kang YJ. Zinc inhibition of caspase-3 activation does not protect HeLa cells from apoptotic cell death. Toxicol Appl Pharmacol. 2001;175:89-93.
38. 2+ concentration of the endoplasmic reticulum is a key determinant of ceramide-induced apoptosis: significance for the molecular mechanism of Bcl-2 action. Embo J. 2001;20:2690-2701.
39. Zhang JH, Chung TD, Oldenburg KR. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen. 1999;4:67-73.
40. Zamaraeva MV, Sabirov RZ, Maeno E, Ando-Akatsuka Y, Bessonova SV, Okada Y. Cells die with increased cytosolic ATP during apoptosis: a bioluminescence study with intracellular luciferase. Cell Death Differ. 2005;12:1390-1397.
41. Pink JJ, Wuerzberger-Davis S, Tagliarino C, Planchon SM, Yang X, Froelich CJ, Boothman DA. Activation of a cysteine protease in MCF-7 and T47D breast cancer cells during beta-lapachone-mediated apoptosis. Exp Cell Res. 2000;255:144-155.
42. Albayrak T, Scherhammer V, Schoenfeld N, Braziulis E, Mund T, Bauer MK, Scheffler IE, Grimm S. The tumor suppressor cybL, a component of the respiratory chain, mediates apoptosis induction. Mol Biol Cell. 2003;14:3082-3096.
43. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA, Munday NA, Raju SM, Smulson ME, Yamin T-T, Yu VL, Miller DK, Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature. 1995;376:37-43.
44. Calvaruso G, Giuliano M, Portanova P, De Blasio A, Vento R, Tesoriere G. Bortezomib induces in HepG2 cells IkappaBalpha degradation mediated by caspase-8. Mol Cell Biochem. 2006;287:13-19.
45. Betts JC, Cheshire JK, Akira S, Kishimoto T, Woo P. The role of NF-kappa B and NF-IL6 transactivating factors in the synergistic activation of human serum amyloid A gene expression by interleukin-1 and interleukin-6. J Biol Chem. 1993;268:25624-25631.
46. Park SG, Lee T, Kang HY, Park K, Cho KH, Jung G. The influence of the signal dynamics of activated form of IKK on NF-kappaB and anti-apoptotic gene expressions: a systems biology approach. FEBS Lett. 2006;580:822-830.
47. Shaner NC, Steinbach PA, Tsien RY. A guide to choosing fluorescent proteins. Nat Meth. 2005;2:905-909.
48. Sala-Newby GB, Taylor KM, Badminton MN, Rembold CM, Campbell AK. Imaging bioluminescent indicators shows Ca2+ and ATP permeability thresholds in live cells attacked by complement. Immunology. 1998;93:601-609.
49. Ayoub MA, Maurel D, Binet V, Fink M, Prezeau L, Ansanay H, Pin JP. Real-time analysis of agonist-induced activation of protease-activated receptor 1/Galphai1 protein complex measured by bioluminescence resonance energy transfer in living cells. Mol Pharmacol. 2007;71:1329-1340.
50. Gross S, Piwnica-Worms D. Spying on cancer: molecular imaging in vivo with genetically encoded reporters. Cancer Cell. 2005;7:5-15.